gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · PLSEHealthcareSurgical Instruments

Pulse Biosciences, Inc Common Stock (DE) (PLSE)

$57.06+9.31%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$57.06▲ 255.29% in range
Nov 4, 2025Low $12.66 · High $57.06Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Pulse Biosciences, Inc Common Stock (DE) closed at $57.06 on Nov 4, up 9.31% — matching its 52-week closing high. Volume of 500.1K shares was 1.34× its 20-day average (above normal).

Split-adjusted performance: +14.7% over one month, +197.0% over six months, +239.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $434K, with a net margin of -5681.3%.

Short interest was 3.0M shares at the Oct 15 settlement, down 9.3% from the prior report (16.4% of float, 7.2 days to cover).

Market cap$4.07B71.3M shares
Revenue · quarter$434.0K—
Diluted EPS$-0.36—
P/E · TTM—P/S 3,434.3×
Net margin-5,681.3%Gross 37.1%
Dividend yieldNone
52-week range12.66 – 57.060.0% from high
Volume500.1K1.34× 20-day avg
Volatility · 60d62.4%Annualised
Short % of float16.4%7.2 days to cover
Net cash$101.6MCash $101.6M
Next earnings—Not scheduled
Split-adjusted performance
1W +6.3%1M +14.7%3M +49.2%6M +197.0%YTD +315.6%1Y +239.8%3Y +1193.9%5Y +177.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum99
Revenue growth—
Net margin2
Value (low P/E)—
Size81

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short3.0M−9.3% vs prior
Days to cover7.2Settled Oct 15
% of float16.4%
Short vol. 10d54.1%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
PLSEPulse Biosciences, Inc Common Stock (DE)$57.06+9.31%+197.0%—−5681.3%—$4.07B
ICUIICU Medical$172.62+6.67%+44.3%+0.5%3.5%143.5$4.32BCompare
IRTCiRhythm Holdings$134.00+6.04%+13.8%+20.1%−0.2%—$4.42BCompare
HTFLHeartflow$56.57+3.99%+86.8%—−24.6%—$4.92BCompare
ATRCAtriCure$65.53+8.48%+134.0%+12.8%5.8%315.9$3.33BCompare
MMEDMiniMed Group$19.29+2.33%——0.0%—$5.43BCompare
MMSIMerit Medical Systems$90.63+7.69%+47.1%+8.4%10.2%33.9$5.43BCompare
HAEHaemonetics$127.42+5.94%+141.9%+5.6%9.7%60.2$5.80BCompare
TFXTeleflex Incorporated$149.87+7.09%+21.6%+28.9%17.5%—$6.35BCompare

News about Pulse Biosciences, Inc Common Stock (DE)

All news →
Pulse Biosciences (PLSE) Q1 2025 Earnings TranscriptThe Motley Fool · May 4, 2026▲ Positive

Quick answers

What does Pulse Biosciences, Inc Common Stock (DE) do?
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
What is PLSE's market cap?
$4.07B, based on the Nov 4 close of $57.06.
Does Pulse Biosciences, Inc Common Stock (DE) pay a dividend?
No regular cash dividend has been paid in the last year.
How much of PLSE is sold short?
3.0M shares, 16.4% of float, as of Oct 15, 2026.
What sector is PLSE in?
Healthcare, in the Surgical Instruments industry.

About Pulse Biosciences, Inc Common Stock (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

HQ: Hayward, CA116 employeesListed May 18, 2016pulsebiosciences.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology